Activity — David D. Chang, M.D., Ph.D.

2 moves.

Date	Action	Company	Value	Shares Δ	Position after	Impact
Feb 2, 2026	Sell	ALLO Allogene Therapeutics, Inc. Common Stock	$171.5K	-95K -1.80%	5,185,862 1.50% of shares	medium
Mar 16, 2026	Sell	ALLO Allogene Therapeutics, Inc. Common Stock	$118.0K	-48K -0.92%	5,150,599 1.49% of shares	medium